Patents by Inventor Robert Brodzik

Robert Brodzik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250019683
    Abstract: A mutant of the Tritirachium album proteinase K zymogen containing a mutation that increases the efficiency of expression in yeast cells and facilitates the inactivation of mature proteinase K under stress and a method of obtaining it.
    Type: Application
    Filed: November 25, 2022
    Publication date: January 16, 2025
    Inventors: Robert BRODZIK, Arkadiusz POPINIGIS, Justyna LEIBNER-CISZAK, Dominik ZIETKOWSKI, Krzysztof KUR
  • Publication number: 20230406894
    Abstract: The subject of the invention is a freeze-dried and ready-for-lyophilization form of the recombinant human RNase inhibitor of SEQ ID NO 1 of the wild type variant in full size (50 kDa), which retains the properties of a recombinant human RNase inhibitor and can be used in the industrial applications including molecular biology and in vitro diagnostics. The developed formulation as well as the freeze-dried form of the recombinant human RNase inhibitor was successfully prepared for the first time in the full size variant. The subject of the invention is a freeze-dried variant of a recombinant human RNase inhibitor and the process of its production resulting in the formation of a powdered form of an RNase inhibitor, which maintains its functionality and increases its stability. Additionally, a dedicated liquid formulation ready for the freeze-drying process was developed.
    Type: Application
    Filed: November 25, 2021
    Publication date: December 21, 2023
    Inventors: Agnieszka STANISLAWSKA, Justyna LEIBNER-CISZAK, Wioleta LADEMAN, Monika WICKA-GROCHOCKA, Monika KOTKIEWICZ (nee Pokorska), Robert BRODZIK, Jan BALSEWICZ, Arkadiusz POPINIGIS, Dominik ZIETKOWSKI, Krzysztof KUR
  • Publication number: 20230287369
    Abstract: The subject matter of this invention is a new thermolabile PPR nuclease or its enzymatically active fragment exhibiting high catalyst activity in difficult reaction conditions (particularly high concentrations of salts and other additives commonly used in the processes of the purification of proteins and viruses, low temperatures and wide range of pH), where the nuclease sequence is SEQ. 2 or a sequence that shares at least 40% of its identity. The subject matter of the invention is also the gene encoding PPR nuclease or its enzymatically active fragment; a particle of nucleic acid encoding the PPR nuclease or its enzymatically active fragment; expression plasmid including the sequence of the PPR encoding gene; recombinant strains of Escherichia coli JM109(DE3) pD454-PPR-AmpR and E. coli ArcticExpress (DE3) pD454-PPR-AmpR; the method of PPR nuclease protein production, application of PPR nuclease in processes of purification of recombinant proteins of significantly lower DNA content.
    Type: Application
    Filed: September 14, 2020
    Publication date: September 14, 2023
    Applicant: Blirt S.A.
    Inventors: Marcin Olszewski, Rafat Walkusz, Wioleta Lademan, Jan Balsewicz, Arkadiusz Popinigis, Dominik Zietkowski, Krzysztof Kur, Robert Brodzik